Warfarin, antiplatelet drugs and their interactions

Australian Prescriber

Volumn 25, Issue 4, 2002, Pages 81-85

  Ho, Lye Lin ^a   Brighton, Timothy ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

Anticoagulants; Aspirin; Dipyridamole; IIb IIIa antagonists; Non steroidal anti inflammatory drugs; Thienopyridines

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DIPYRIDAMOLE; EPTIFIBATIDE; NONSTEROID ANTIINFLAMMATORY AGENT; THIENO[2,3 B]PYRIDINE DERIVATIVE; TIROFIBAN; WARFARIN;

BLEEDING; DRUG EFFECT; HUMAN; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

EID: 0036331923     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2002.073     Document Type: Review

References (16)

1. Side effects of antithrombotic therapy
2. Antiplatelet therapy for acute ischaemic stroke
3. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
4. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomised, controlled trial
5. Meloxicam, 15 mg/day, spares platelet function in healthy volunteers
6. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
7. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
8. The antiplatelet effects of ticlopidine and clopidogrel
9. Unstable angina pectoris
10. Anti-GPIIb/IIIa drugs: Current strategies and future directions
11. Consensus guidelines for warfarin therapy. Recommendations from the Australasian Society of Thrombosis and Haemostasis
12. The management of coumarin-induced over-anticoagulation
13. Interaction of celecoxibandwarfarin
14. Interaction of rofecoxib with warfarin
15. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
16. Management and dosing of warfarin therapy